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ABSTRACT
Ergosterol, a component of fungal cell membrane, has been frequently detected as an indicator of fungal presence and mass 
in environmental samples like soil. However, its detection in major pathogenic fungal species has not been investigated. 
In this study, the ergosterol contents of ten pathogenic fungal species were determined. Liquid chromatography was used 
for the detection and quantification of ergosterol extracted from fungal broth cultures. Results showed that ergosterol 
eluted as a single, well resolved peak in the chromatogram profiles of all tested fungi. Based upon relative amounts of 
ergosterol produced per fungal mycelial dry weight, three groups of fungal pathogens were identified, namely low ergosterol 
(Aspergillus niger, Candida albicans and Cryptococcus neoformans at 4.62, 6.29 and 7.08 µg/mg, respectively), medium 
ergosterol (Fusarium solani, Aspergillus fumigatus, Mucor sp., Penicillium sp., Cryptococcus gattii and Rhizopus sp. 
at 9.40, 10.79, 10.82, 11.38, 12.60 and 13.40 µg/mg, respectively), and high ergosterol (Candida tropicalis at 22.84 µg/
mg), producers. Ergosterol was not detectable in bacterial samples, which were included as controls. This first report on 
ergosterol detection in major pathogenic fungal species indicates that ergosterol may be used as a biomarker to diagnose 
invasive fungal infections in clinical samples.
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ABSTRAK
Ergosterol, yang merupakan komponen membran sel fungus, seringkali dikesan sebagai petunjuk kehadiran dan jumlah 
fungus dalam sampel daripada persekitaran. Walau bagaimanapun, pengesanan ergosterol dalam fungus patogen utama 
belum dikaji. Dalam kajian ini, kandungan ergosterol dalam sepuluh spesies fungus patogen telah ditentukan. Kaedah 
kromatografi cecair digunakan untuk mengesan kehadiran dan penentuan kuantiti ergosterol yang diekstrak daripada 
kultur kaldu fungus. Berdasarkan kuantiti relatif ergosterol yang terhasil pada miselia fungus (berat kering), tiga 
kumpulan dikenal pasti iaitu mengandungi, ergosterol rendah (Aspergillus niger, Candida albicans dan Cryptococcus 
neoformans pada 4.62, 6.29 dan 7.08 µg/mg masing-masing), ergosterol sederhana (Fusarium solani, Aspergillus 
fumigatus, Mucor sp., Penicillium sp., Cryptococcus gattii dan Rhizopus sp. pada 9.40, 10.79, 10.82, 11.38, 12.60 dan 
13.40 µg/mg masing-masing) dan ergosterol tinggi (Candida tropicalis pada 22.84 µg/mg). Ergosterol tidak dapat 
dikesan pada sampel bakteria yang digunakan sebagai kawalan. Laporan pertama pengesanan ergosterol pada fungus 
patogen utama ini, menunjukkan bahawa ergosterol mungkin boleh digunakan sebagai biomarker untuk pendiagnosan 
jangkitan fungus invasif dalam sampel klinikal.
Kata kunci: HPLC; ergosterol; biomarker; patogenik; fungus
INTRODUCTION
Ergosterol is a basic sterol forming the cellular membranes 
of moulds, yeasts and many fungi (Gutarowska et al. 
2015). Many correlations between ergosterol content and 
fungal biomass revealed the specificity of ergosterol as an 
indicator of fungi to detect and identify fungal colonization 
and establish their proliferation potential in plants (Chow 
et al. 2017). Ergosterol quantification is more useful than 
the direct microscopic count, fluorescence microscopy or 
staining method, as these methods often lead to under- 
or over-estimation of fungal biomass (Chiocchio & 
Matkovic 2011). The analysis of ergosterol content has 
been utilized for various applications including assessing 
agriculture quality (Ruzicka et al. 2000), food deterioration 
during transportation (Dong et al. 2006), mold growth 
in buildings and airborne particulates for subsequent 
predictions of indoor air quality (Hippelein & Rügamer 
2004; Axelsson et al. 1995). The first studies on the use 
of ergosterol as an indicator of the presence of mould in 
the environment were done by Seitz et al. (1977, 1979). 
Growth of Alternaria alternata, Aspergillus flavus, and 
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Aspergillus amstelodami (Aspergillus glaucus group) on 
moist, milled rice at 25oC was monitored by ergosterol 
and chitin assays. Other important grain fungi that were 
strong ergosterol producers were Aspergillus candidus, 
A. ochraceus, Penicillium brevi-compactum, Fusarium 
moniliforme, and F. roseum. The ergosterol assay therefore 
was shown to have usefulness for selecting grain hybrids 
with resistance to weathering and discoloration caused by 
fungi (Seitz et al. 1977).
The ergosterol assay provides a useful method for 
quantifying fungal growth, so numerous studies have 
assessed the relationship between fungal growth and 
ergosterol production (John & Hocking 2009), however, 
ergosterol analysis has thus far not been explored for 
clinical applications as an indicator of fungal infection 
in patients. Ergosterol detection in plasma and urine of 
rats has been performed in pharmacokinetic studies of 
ergosterol in experimental animals (Chen et al. 2013).
The number of opportunistic fungal infections 
has increased significantly during the past decades, 
at least in part as the result of a rising number of 
immunocompromised patients. Individuals at risk for 
the development of a serious fungal infection include 
patients undergoing solid-organ, blood and bone marrow 
transplantation, cancer patients, patients with the acquired 
immunodeficiency syndrome (AIDS) and other patients 
receiving immunosuppressive treatment (Pfaller & 
Diekema 2004; Brakhage 2005). Today, invasive fungal 
infections are among the most challenging problems 
in haematology, oncology and intensive care medicine 
(Vandewoude et al. 2006). Among the approximately 
140 000 known fungal species only a few cause human 
infections (Richardson & Warnock 2003). The most 
predominant pathogens are the yeast Candida albicans 
and the filamentous fungus Aspergillus fumigatus, 
but other fungal pathogens frequently cause systemic 
infections, such as the yeast species C. glabrata, C. 
krusei, C. tropicalis, Cryptococcus and Trichosporon, 
filamentous fungi such as Aspergillus, Fusarium, 
Rhizopus and Mucor, and dematiaceous hyphomycetes 
(Richardson 2005).
Diagnostic assays for invasive fungal infections 
include detection of biomarkers such as mannan for 
Candida species, galactomannan for Aspergillus species 
(Bašková & Vladimír 2012) and beta-glucan for various 
fungal species (Karageorgopoulos et al. 2011). Reliable and 
reproducible diagnostic performance, standardized inter-
laboratory procedures, easy application, rapid availability 
of results and cost-effectiveness are the main features 
required for the use of a diagnostic test in routine clinical 
practice. Many of the currently available diagnostic assays 
for invasive fungal infections lack these features.
Although ergosterol has been detected in fungi 
that especially contaminate environmental and building 
samples (Pasanen et al. 1999), its analysis as a biomarker 
of infection has not been applied to pathogenic fungi. 
Therefore in this study, the concentration of ergosterol in 
ten important fungal pathogen species were determined 
to evaluate its usefulness as a biomarker for fungal 
infections.
MATERIALS AND METHODS 
FUNGI
Ten pathogenic fungal isolates (Aspergillus fumigatus, 
Aspergillus niger, Candida albicans, Candida tropicalis, 
Cryptococcus gattii, Cryptococcus neoformans, Fusarium 
solani, Mucor sp., Penicillium sp., Rhizopus sp.) obtained 
from clinical specimens, maintained on 1.5% (weight/
volume, wt/v) potato dextrose agar (PDA) slants, were 
transferred onto PDA plates and incubated for seven 
days. At the end of the incubation period, a piece of 
agar, 5 mm in diameter, was cut aseptically from the 
active growing edge of each fungus and transferred to 1 
L flasks containing 500 mL of potato dextrose broth. The 
flasks were incubated on a rotary shaker at 125 rpm and 
37ºC for 1 week. At the end of the incubation period, the 
contents of each flask were filtered through sterile gauze. 
Fungal mycelia trapped in the gauze were washed three 
times with 100 ml of sterile de-ionized water. The mycelia 
were freeze-dried. Freeze-dried mycelia were kept in 
clean sample bottles capped with lined caps and kept in 
a desiccator until used.
BACTERIA
Four bacterial species (Bacillus subtilis, Escherichia 
coli, Pseudomonas aeruginosa, Staphylococcus aureus) 
representing Gram positive and Gram negative bacteria 
frequently encountered in the clinical setting, were 
subcultured onto nutrient agar for 24 hours and transferred 
to 500 mL flasks containing 250 mL of nutrient broth. The 
flasks were incubated on a rotary shaker at 125 rpm and 
37oC for two days. These pathogenic bacterial isolates 
were included as controls to determine the presence of 
ergosterol.
EXTRACTION OF ERGOSTEROL
Exactly 100 mg of freeze-dried mycelia and biomass, for 
each fungal and bacteria species, were blended with 100 
mL methanol in a Waring micro-blender and transferred 
to a 250 mL round bottom flask. The Waring blender was 
washed with 50 mL methanol and the contents added to the 
round bottom flask. To the latter, 3.4 g of sodium hydroxide 
and 50 mL of 95% ethanol were then added and left for one 
hour at room temperature to saponify the sterol esters. After 
cooling, the contents were centrifuged at 500 rpm for 30 
minutes. The supernatant was transferred to a separatory 
funnel, 50 mL of water added and extracted twice with 100 
mL of pentane. The pentane fraction was concentrated in 
a rotary evaporator and redissolved in 3 mL of methanol-
dichloromethane mixture (1:1). The method of ergosterol 
JSKM16(2) 3.indd   16 17/05/2018   3:25:39 PM
17
extraction and detection used in this study was according 
to Dawson-Andoh (2002).
FRACTIONATION AND DETECTION OF ERGOSTEROL
The re-dissolved pentane fraction in methanol-
dichloromethane (1:1) was filtered through a 45 µm PTFE 
membrane filter (CHROMAFIL Xtra) and analyzed by High 
Performance Chromatography with a Waters 2695 Alliance 
Separations Modules composed of a quaternary pump, 
a column oven, and Waters 2487 dual Diode Array 
Detector (DAD), and Empower software was used for data 
collection. 20 µL of sample was injected per analysis. 
The samples were fractionated on an Ascentis C18 HPLC 
Column (25 cm × 4.6 mm, 5 microns) at a flow rate of 1.5 
ml per minute with a methanol-water gradient system as 
previously published (Dawson-Andoh 2002). The column 
temperature was maintained at 40ºC and the UV detector 
was set at 254 nm (0.1 absorbances). The reverse phase 
column was coupled to a C18 guard column (Waters). 
Ergosterol (Sigma 45480) external standard at 10, 20, 40, 
50, 100, 300, 500, 800 and 1000 µg per mL was used to 
plot a calibration curve.
RESULTS
Calibration curves of ergosterol standard were found to 
be linear with the values of 269223, 626850, 1221806, 
1312314, 2958753, 10758018, 16089992, 27051242 and 
29694650 over the ergosterol standard of 10, 25, 40, 50, 
100, 300, 500, 800, and 1000 µg/mL, respectively (Figure 
1 & Table 1). The elution time for the ergosterol standard 
was between 12.991-13.032 minutes. Chromatograms 
FIGURE 1. Calibration curve of ergosterol standard
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TABLE 1. HPLC results for ergosterol standard 
 Ergosterol HPLC RT*/ HPLC HPLC
 Concentration/ minutes peak area peak height
 µgmL–1   
 1000 13.032 29694650 2285723
 800 13.026 27051242 2197821
 500 13.026 16089992 1496168
 300 13.016 10758018 975950
 100 13.001 2958753 258676
 50 13.005 1312314 115258
 40 12.998 1221806 107711
 25 12.994 626850 55205
 10 12.991 269223 23596
*RT = retention time
of the ergosterol standard at different concentrations are 
shown in Figure 2.
TABLE 2. Ergosterol content of fungal and bacterial isolates determined by HPLC
 Sample Isolate HPLC HPLC RT/ Ergosterol *Ergosterol
 no.  result minutes concentration/ content in
     µgmL–1  mycelia/µgmg–1
1-Af Aspergillus fumigatus positive 13.003 359.59 10.79
2-An Aspergillus niger positive 12.969 153.89 4.62
3-Ca Candida albicans positive 12.998 209.58 6.29
4-Ct Candida tropicalis positive 12.975 761.25 22.84
5-Crg Cryptococcus gattii positive 12.980 419.86 12.60
6-Crn Cryptococcus neoformans positive 13.007 235.99 7.08
7-Fs Fusarium solani positive 13.009 313.36 9.40
8-Mu Mucor positive 13.016 360.72 10.82
9-Pe Penicillium positive 13.032 379.21 11.38
10-Rh Rhizopus positive 13.009 446.53 13.40
11-Bs Bacillus subtilis Negative - 0 -
12-Ec Escherichia coli Negative - 0 -
13-Pse Pseudomonas aeruginosa Negative - 0 -
14-Ste Staphylococcus aureus Negative - 0 -
*Ergosterol concentration calculated per mg dry mycelial weight
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FIGURE 2. Chromatograms of ergosterol standard at varying concentrations
HPLC results of extracts from fungal and bacterial isolates 
are shown in Table 2. Ergosterol in saponified extracts was 
identified by comparison of its retention time with that of 
external ergosterol standard. The ergosterol peak was well 
resolved and eluted at between 12.969-13.032 minutes. No 
detectable interfering peaks were observed. C. tropicalis and 
A. niger yielded the highest and lowest levels of ergosterol 
respectively. On the basis of relative levels of ergosterol 
produced, these fungi can be placed into three groups: high 
ergosterol (Candida tropicalis, 22.84 µg/mg), medium 
ergosterol (Rhizopus, Cryptococcus gattii, Penicillium, 
Mucor, Aspergillus fumigatus and Fusarium solani at 13.40, 
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FIGURE 3. Chromatograms of ergosterol in pathogenic fungal isolates studied Af: Aspergillus fumigatus; An: Aspergillus niger; Ca: 
Candida albicans; Ct: Candida tropicalis; Crg: Cryptococcus gattii; Crn: Cryptococcus neoformans; Fs: Fusarium solani; Mu: 
Mucor sp.; Pe: Penicillium sp.; Rh: Rhizopus sp.
12.60, 11.38, 10.82, 10.79 and 9.40 µg/mg respectively), 
and low ergosterol (Cryptococcus neoformans, Candida 
albicans and Aspergillus niger at 7.08, 6.29 and 4.62 µg/mg 
respectively) (Table 2). The levels of ergosterol in these fungi 
were measurable and could therefore be used to detect fungal 
presence in clinical samples. Bacterial isolates did not show 
any positive result (no ergosterol peak detected) because 
they do not contain ergosterol. The bacteria were included 
in this study as it is necessary to differentiate between 
bacterial and fungal infections in clinical applications. The 
chromatograms of ergosterol extracted from pathogenic 
fungal isolates are shown in Figure 3.
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DISCUSSION
Although ergosterol is specific to fungi and may be 
used as a relative index of associated fungal biomass, its 
concentration does not always correlate with absolute 
fungal biomass (Gessner & Chauvet 1993). Concentration 
of ergosterol in a fungus is influenced by both internal 
and external factors, such as fungal species (Huang et al. 
1985; Newell et al. 1987; Salmanowicz & Nylund 1988), 
physiological state of fungus, its age, developmental stage 
(Huang et al. 1985), general growth conditions, chemical 
composition of substrate, temperature and pH of the 
environment (Weete 1980; Arnezeder & Hampel 1991; 
Olsen 1973; Vanden 1990). However, in contrast to large 
differences in ergosterol content of macrofungal fruiting 
bodies reported by Huang et al. (1985), Gessner & Chauvet 
(1993) observed very little dependence of ergosterol 
content of fourteen strains of aquatic hyphomycetes 
commonly found on decaying leaves on external factors 
such as media composition and age of culture. Although 
ergosterol content may vary in a fungal species under 
differing conditions, for clinical applications, it is more 
relevant that ergosterol is detectable in a patient as this 
may have both diagnostic and prognostic value.
In the present study, we have shown that the ergosterol 
content in pathogenic fungi is measurable and varies in 
different species. Ergosterol is a structural component of 
the fungal cell membrane and there have been no reports 
linking its content to fungal pathogenicity. We have 
also shown that ergosterol is not detectable in bacterial 
isolates, therefore it may be a highly specific indicator 
of fungal presence. Determination of ergosterol content 
may indicate the susceptibility of the fungus to antifungal 
drugs, as enzymes involved in the synthesis of ergosterol 
are the target of azole antifungal drugs. A previous study 
had shown that the quantitation of ergosterol content in 
C. albicans isolates, following exposure to the azole drug 
fluconazole, was useful for discerning susceptibility to 
the drug, enabling the discrimination between resistant 
and highly resistant isolates (Arthington-Skaggs et al. 
1999) and appeared more predictive of in vivo outcome 
compared to conventional susceptibility testing in an 
animal study (Arthington-Skaggs et al. 2000). In resistant 
C. albicans isolates, ergosterol content did not decrease 
as much as in sensitive isolates, following fluconazole 
treatment (Arthington-Skaggs et al. 1999). Based on these 
results, therefore detection and quantification of ergosterol 
periodically in a patient with invasive fungal infection may 
be useful for therapeutic drug monitoring, especially when 
azole antifungal drugs are prescribed.
CONCLUSION
In conclusion, the detection of ergosterol in clinical 
specimens may be a very useful biomarker especially for 
the diagnosis of invasive fungal infections.
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